Clinical Trials on Lung Biopsy in New Zealand

Total 6577 results

Memorial Sloan Kettering Cancer Center

Completed

Registry for Patients With Acquired Resistance to Small Molecule Kinase Inhibitors in Non-Small-Cell Lung Cancer

Unresectable or Metastatic Non-small Cell Lung Cancer (NSCLC)

United States
Bayer

Terminated

Determination of Safety, Efficacy, and Pharmacokinetics of "Regorafenib" Combined With Pemetrexed and Cisplatin in Patients With Nonsquamous Non-Small Cell Lung Cancer

Small Cell Lung Carcinoma

United States
Ludwig Institute for Cancer Research
National Cancer Institute (NCI)

Completed

Monoclonal Antibody Therapy in Treating Patients With Progressive Small Cell Lung Cancer (SCLC)

Lung Cancer

United States
Weill Medical College of Cornell University
Bristol-Myers Squibb

Terminated

Radiation and Immune Checkpoints Blockade in Metastatic NSCLC (BMS # CA209-632)

Non Small Cell Lung Cancer Metastatic

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Epothilone D in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Platinum-Based Chemotherapy

Lung Cancer

United States
Memorial Sloan Kettering Cancer Center

Active, not recruiting

Informing the Adaptation of a CHW Model to Facilitate Lung Cancer Screening for the Chinese Community

Lung Cancer Screening | Current or Past Cigarette Smoker

United States
Roswell Park Cancer Institute

Completed

Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Stage III-IV Non-small Cell Lung Cancer

Stage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer

United States
Lyra Therapeutics

Completed

LYR-210 Depot (LYR-210) for Adult Subjects With Chronic Sinusitis (LANTERN Study)

Chronic Sinusitis | Chronic Rhinosinusitis (Diagnosis)

Poland, Australia, New Zealand, Austria, Czechia
NYU Langone Health
National Cancer Institute (NCI)

Completed

Computed Tomography for Early Detection of Cancer in Women Who Are at Risk for Lung Cancer

Lung Cancer

United States
Io Therapeutics
Dartmouth College

Suspended

Study of IRX4204 With Erlotinib in Previously Treated Advanced NSCLC

Lung Cancer, Nonsmall Cell

United States
Konstantin Dragnev
Abbott

Terminated

Pharmacokinetic & Pharmacodynamic Study of ABT-751 With Carboplatin in Patients With Advanced Lung Cancer

Lung Cancer | Non Small Cell Lung Cancer

United States
The Cooper Health System

Unknown

Stereotactic Radiosurgery and Systemic Dose Chemotherapy for Locally Advanced Lung Cancer

Non Small Cell Lung Cancer

United States
Memorial Sloan Kettering Cancer Center

Completed

Irreversible Electroporation Ablation for Colorectal Metastases to the Lung

Colorectal Metastases to the Lung

United States
Memorial Sloan Kettering Cancer Center
Sanofi

Completed

Docetaxel (Taxotere), Vinorelbine, and Bevacizumab, as Adjuvant Chemotherapy for Patients With Resected Stage I-III Non-small Cell Lung Cancer

Lung Cancer

United States
Memorial Sloan Kettering Cancer Center

Completed

Survey and Blood Sample Collection for Patients With Lung Cancer Who Never Smoked Cigarettes

Lung Cancer

United States
Roswell Park Cancer Institute

Completed

Nimotuzumab and Nivolumab in Treating Patients With Advanced Non-small Cell Lung Cancer

Stage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | EGFR Gene Mutation

United States
Memorial Sloan Kettering Cancer Center
Amgen

Recruiting

A Study Comparing Sotorasib With Durvalumab in People With Non-Small Cell Lung Cancer (NSCLC)

Non-Small Cell Lung Cancer

United States
Memorial Sloan Kettering Cancer Center

Terminated

DS-3201b and Irinotecan for Patients With Recurrent Small Cell Lung Cancer

Small Cell Lung Cancer

United States
University of Rochester

Recruiting

Study of Pembrolizumab and Single Agent Chemotherapy as First Line Treatment for Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer With Eastern Cooperative Oncology Group (ECOG) Performance Status of 2

Non-small Cell Lung Cancer

United States
Albert Einstein College of Medicine
Celldex Therapeutics

Terminated

FLT3 Ligand, CD40 Agonist Antibody, and Stereotactic Radiotherapy (FLT3)

Lung Cancer | Non Small Cell Lung Cancer

United States
Novartis Vaccines
Department of Health and Human Services

Completed

Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Elderly Subjects

Pandemic H5N1 Influenza

United States, Australia, New Zealand, Thailand
CSL Behring

Completed

Safety, Efficacy and Pharmacokinetics of ALD518 in Patients With Non-Small Cell Lung Cancer-related Fatigue and Cachexia

Fatigue | NSCLC | Cachexia

Canada, Australia, Russian Federation, Georgia, Serbia, India, New Zealand, Poland, Romania
Icahn School of Medicine at Mount Sinai

Recruiting

Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLC

Non-Small Cell Lung Cancer

United States
Weill Medical College of Cornell University

Completed

Collection of Blood for Gene Expression Study in Individuals With Chronic Lung Diseases

Pulmonary Diseases

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI); Duke University

Completed

Lung Cancer Exercise Training Study

Lung Cancer

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI); University of Southern California

Completed

Methylated Genes in Blood as Biomarkers for Advanced Lung Cancer

Lung Cancer

United States
Montefiore Medical Center
Eli Lilly and Company

Terminated

Necitumumab in the Neoadjuvant Setting With Gemcitabine in Surgically Resectable - 14X-US-I001

Squamous Cell Lung Cancer

United States
Columbia University
National Heart, Lung, and Blood Institute (NHLBI); University of Iowa; Weill... and other collaborators

Completed

Families-At-risk for Interstitial Lung Disease Study (FAR-ILD)

Idiopathic Pulmonary Fibrosis | Interstitial Lung Disease

United States
Memorial Sloan Kettering Cancer Center

Completed

Multimodality Treatment for Patients With Resectable Non-Small Cell Lung Cancer (NSCLC) - BEACON Study: Bevacizumab and Chemotherapy for Operable NSCLC

Carcinoma, Non-Small-Cell Lung

United States
Memorial Sloan Kettering Cancer Center
GE Healthcare

Terminated

Breathing Synchronized PET/CT Scans for the Detection of Malignant Lung & Liver Lesions and Assessment of Tumor Glycolysis

Lung Cancer | Non-small Cell Lung Cancer

United States
Dartmouth-Hitchcock Medical Center

Completed

Phosphoproteomic Patterns as a Novel Biomarker for Aurora and Polo-like Kinase Inhibitors in Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

United States
Montefiore Medical Center
Genentech, Inc.

Completed

OSI-774 (Erlotinib, Tarceva) in Elderly Patients

Non-Small Cell Lung Cancer

United States
Dartmouth-Hitchcock Medical Center
Genentech, Inc.; Ligand Pharmaceuticals

Completed

Study of Tarceva and Targretin in Stage I-II Lung Cancer

Carcinoma, Non-small-cell Lung

United States
Atlantic Health System

Terminated

Safety Study: Combined Modality Treatment for Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

United States
Yale University
National Cancer Institute (NCI); Merck Sharp & Dohme LLC; NextCure, Inc.

Recruiting

The Study of NC318 Alone or in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer

Advanced Non-small Cell Lung Cancer

United States
Yale University
Merck Sharp & Dohme LLC

Completed

Vorinostat in Combination With Palliative Radiotherapy for Patients With Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer (NSCLC)

United States
University of Rochester
Celgene Corporation

Withdrawn

Abraxane and RT for Non-Small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer, Stage III

United States
Western Sydney Local Health District
University of Western Sydney

Recruiting

Liver Toxicity in Lung Cancer Patients Treated With Immune-checkpoint Inhibitors.

Hepatitis | Lung Cancer, Non-small Cell | Lung Cancer Stage IV

Australia
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Gefitinib and Everolimus in Treating Patients With Stage IIIB or Stage IV or Recurrent Non-Small Cell Lung Cancer

Lung Cancer

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer

Lung Cancer

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

10-Propargyl-10-Deazaaminopterin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Lung Cancer

United States
NYU Langone Health
National Cancer Institute (NCI)

Completed

R115777 in Treating Patients With Relapsed Small Cell Lung Cancer

Lung Cancer

United States
Boehringer Ingelheim

Completed

Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients

Pulmonary Disease, Chronic Obstructive

United States, Argentina, Australia, Austria, Belgium, Canada, Chile, Germany, Italy, New Zealand
Memorial Sloan Kettering Cancer Center
Bristol-Myers Squibb

Completed

Evaluate the Mediators of Sensitivity and Resistance to Nivolumab Plus Ipilimumab in Patients With Advanced NSCLCs

Advanced Stage Non-small Cell Lung Cancer

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

TLK286 in Treating Patients With Advanced Non-Small Cell Lung Cancer

Lung Cancer

United States
Memorial Sloan Kettering Cancer Center
University of Florida; Weill Medical College of Cornell University; Hamad Medical... and other collaborators

Active, not recruiting

Clinician-Patient Communication in Lung Cancer Care

Lung Cancer

United States
Deep Breeze

Unknown

Vibration Response Imaging (VRI) in Patients Who Are Potential Candidates for Surgical Resection

Lung Cancer

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI); National Institutes of Health (NIH)

Active, not recruiting

Prognostic Value of Tumor Hypoxia, as Measured by 18F-FMISO Breath Hold PET/CT, in Non-Small-Cell-Lung Cancer (NSCLC) Patients

Non-Small-Cell-Lung Cancer (NSCLC)

United States
The University of Queensland
University of Copenhagen; Erasmus Medical Center; Monash University; Hôpital Cochin and other collaborators

Recruiting

Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT)

Pulmonary Disease Due to Mycobacteria (Diagnosis)

Australia, Canada, Denmark, France, Ireland, Netherlands, New Zealand, United Kingdom, Singapore
Albert Einstein College of Medicine
Celldex Therapeutics

Active, not recruiting

FLT3 Ligand Immunotherapy and Stereotactic Radiotherapy for Advanced Non-small Cell Lung Cancer (FLT3)

Non-small Cell Lung Cancer (NSCLC)

United States

Clinical Trials on Lung Biopsy in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lebanon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations